Nerve Block for Reducing Pain After Wisdom Tooth Extraction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to reduce pain after wisdom teeth removal. The study focuses on a special nerve block, the Temporo-masseteric Nerve Block, which could ease pain in the first week after surgery. Participants will report their pain levels and any pain medications used during this period. This trial may suit individuals healthy enough for dental surgery under sedation and who can use a smartphone. As a Phase 2 trial, the research measures the treatment's effectiveness in an initial, smaller group.
Do I need to stop my current medications for this trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you have an allergy to dental local anesthetics or cannot tolerate common pain medications like opioids, acetaminophen, or ibuprofen, you may not be eligible to participate.
What prior data suggests that the Temporo-masseteric Nerve Block is safe for reducing pain after wisdom tooth extraction?
Research has shown that the Temporo-masseteric Nerve Block (TMNB) is safe and effective for easing pain after dental surgery. Studies have found that TMNB quickly relieves jaw pain, and the relief lasts without serious side effects. Although more research is needed, early results suggest that patients tolerate this treatment well. TMNB uses a standard dental anesthetic, which is widely used and known to be safe.12345
Why are researchers excited about this trial's treatment?
The Temporo-masseteric Nerve Block (TMNB) is unique because it targets the nerves specifically responsible for pain after wisdom tooth extraction, unlike standard pain management options like oral painkillers or general local anesthetics that work more broadly. Researchers are excited about this treatment because it uses a targeted nerve block with a specific anesthetic, 2% lidocaine with epinephrine, which can potentially provide more precise and effective pain relief right at the source, potentially reducing the need for systemic pain medications. This approach may also minimize side effects and improve recovery time, offering a more efficient pain management solution after dental surgery.
What evidence suggests that the Temporo-masseteric Nerve Block is effective for reducing pain after wisdom tooth extraction?
Studies have shown that the Temporo-masseteric Nerve Block (TMNB), which participants in this trial will receive, effectively reduces jaw pain after wisdom tooth extractions. Research indicates that TMNB provides quick and lasting pain relief and alleviates muscle spasms around the jaw. By targeting specific nerves in the jaw, this nerve block may reduce pain and stiffness. Early evidence supports its potential to ease discomfort from dental procedures, making it a promising option for those undergoing wisdom tooth removal.46789
Who Is on the Research Team?
Gayathri D Subramanian, PhD, DMD
Principal Investigator
Rutgers School of Dental Medicine
Are You a Good Fit for This Trial?
This trial is for adults aged 18-64 who need their lower wisdom teeth removed and can consent to the study. They must be healthy enough for sedation, not pregnant, have internet access with a smartphone, and able to take common pain meds like Tylenol or Advil.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Procedure and Immediate Post-Procedure
Participants undergo lower wisdom molar extraction under intravenous sedation and receive the TMNB injection. Pain scores are recorded up to 4 hours post-procedure.
Post-operative Monitoring
Participants' pain experience and medication use are monitored daily for one week post-procedure. Adverse effects are also recorded.
Follow-up
Participants return for a post-operative evaluation to assess healing and any adverse effects.
What Are the Treatments Tested in This Trial?
Interventions
- Temporo-masseteric Nerve Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor